Explore This Research Award in CaptureIQ
Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.
Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- LYNNTECH INC.
- Proposal award date
- 2020-12-11
- Contract end date
- 2021-11-30
- UEI
- PMVAL8J63516
- Solicitation number
- PA19-272
- Topic code
- NIAID
Research abstract
PROJECT SUMMARYSystems that utilize various filtration media are one of the first lines of defense against aerosolized
pathogens. They are critical in providing a safe/clean environment for patients, medical personnel, or
researchers. Without these filters, those with compromised immune systems, or those working with highly
contagious pathogens, can face deadly situations. Even with these filters in place, certain pathogens have the
potential to pass through or even survive within the filter. Due to the small size of many viruses, the coronavirus
SARS-CoV-2 is ~100nm, no filter is 100% effective at capturing all aerosolized pathogens. Furthermore, re-
aerosolization of certain captured pathogens can also take place during normal use, when the filter is assessed
to determine its remaining lifespan, or when the filter needs to be replaced entirely. Herein lies Lynntech’s focus
in this area. Lynntech plans to address these shortcomings in filtration media through the addition of novel solid
and stable hydroperoxy ligands that will immediately, and continually, terminate captured aerosolized pathogens
such as the coronavirus SARS-CoV-2 virus that causes COVID-19. Self-detoxifying filters would allow for the
complete termination of any pathogen that might normally remain active on untreated filters as well as eliminate
the potential for re-aerosolization of active pathogens. This would allow for not only increased protection of those
relying on the filters, but also mitigate the risks of those who would normally assess or change the filters. Many
of the efforts towards the modification of filtration media for active decontamination have been partially
successful, however, they have all come with their own drawbacks that Lynntech will attempt overcome with its
own method of filter modification. During this Phase 1 project, Lynntech will demonstrate proof-of-concept by
pursuing the following specific aims: (1) functionalization of commercial fiberglass-based filter media with
hydroperoxy ligands, (2) assessment of antimicrobial properties of hydroperoxy-treated filters, and (3) evaluation
of the “irreversibility” and safety of bound hydroperoxy ligands. Successful completion of these specific aims
should demonstrate ample feasibility of using Lynntech’s filter modification technology and allow for Lynntech to
plan more comprehensive technology development and commercialization avenues. Overall, this technology
provides a great opportunity to drastically improve the safety of those who are working or healing in potentially
harmful environments. This technology could even be extended to further decontamination avenues such as
chemical warfare agents, or toxic industrial chemicals.PROJECT NARRATIVE
Lynntech is proposing to enable active decontamination on existing filter media through surface
modifications using novel safe, solid hydrogen peroxide coatings. This material retains the disinfecting
capabilities of traditional hydrogen peroxide but increases upon its safety and stability when exposed
to mechanical and thermal stresses. This treatment procedure is necessary and vital to combat issues
related to the safety concerns caused by the aerosolization of coronavirus SARS-CoV-2.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
Research funding history
1,079 SBIR/STTR records share this UEI (1988–2025). Reported award amounts total $327,411,388. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Defense, Department of Health and Human Services, National Aeronautics and Space Administration, Department of Energy, National Science Foundation, Environmental Protection Agency
Agency intelligence
Department of Health and Human Services
Back to SBIR/STTR Research Awards